Work

A novel analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and provides an option for efficacy assessments that could accelerate drug approvals.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.1069

Authors: Celine Yeh, Mengxi Zhou, Neil Bapodra, Maria Rivero, Edward Jose Espinal Dominguez, Marina Moran, Dawn L. Hershman, Antonio Tito Fojo, Susan Elaine Bates

Institutions: Columbia University, James J. Peters VA Medical Center, Pfizer (Spain)

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W4282020691

Cites:

Cited by:

Related to: 10